EUVIMEDExplore EUVIMED
Crossref

Integrated assessment of the serum magnesium-to-vitamin D3 ratio, micronutrient deficiencies, and inflammatory biomarkers in patients with migraine

R. A. Alrahman, L. Jabbar, S. H. Shalal

Regulatory Mechanisms in Biosystems · 2026-06-14 · 17 (5) · e26093

DOI: 10.15421/0226093 ↗

At a glance

Journal article in Regulatory Mechanisms in Biosystems, published online on 2026-06-14. Written by R. A. Alrahman and 2 co-authors. 13 references.

AbstractBibliographic detailsCiteRelated studies

Abstract (original language)

Migraine is a common neurovascular disease linked to complex metabolic or inflammatory changes that can lead to neuronal hyperexcitability and susceptibility to headache. In this study, associations between the serum magnesium-to-vitamin D 3 (Mg/VitD 3 ) ratio and other micronutrients and inflammatory biomarkers were evaluated and examined as a combined biochemical index in patients with migraine. A case - control study was carried out with 120 adult participants (60 migraine patients and 60 healthy controls of matched age and sex ) . The level of serum magnesium was determined by an automated colorimetric method, and 25-hydroxyvitamin D 3 was determined by enzyme-linked immunosorbent assay (ELISA). Serum calcium, vitamin B 12 , folic acid and C-reactive protein (CRP) were also measured. A Mg/VitD 3 ratio was determined for each individual. There were no significant differences between the two groups for any baseline demographic characteristics. Migraine patients exhibited significantly lower serum vitamin D 3 (18.1 ± 3.2 vs. 28.6 ± 4.3 ng/mL), magnesium (1.39 ± 0.22 vs. 2.00 ± 0.19 mg/dL), calcium (9.08 ± 0.51 vs. 9.32 ± 0.28 mg/dL), vitamin B12 (421.8 ± 193.6 vs. 489.4 ± 87.5 pg/mL), and folic acid (5.7 ± 1.3 vs. 12.4 ± 3.2 ng/mL), whereas CRP levels were markedly elevated (2.56 ± 1.31 vs. 0.48 ± 0.18 mg/L). The Mg/VitD 3 ratio was significantly reduced in migraine patients. All significant correlations were positive, with a strong positive correlation with magnesium (r = 0.843) and vitamin D 3 (r = 0.721); moderate positive correlations with folic acid, vitamin B 12 , and calcium; and a strong negative correlation with CRP (r = −0.589). Only magnesium, vitamin D 3 , folic acid, vitamin B 12 and CRP were independently associated with migraine (logistic regression analysis), while calcium was not. There is also concurrent micronutrient deficiency and syste m ic inflammation in migraine. The ratio of Mg/VitD 3 in serum is a promising integrated biomarker that includes metabolic and inflammatory disturbances and could have the potential to enhance biochemical evaluation and risk stratification in patients with migraine.

Cite

APA

Alrahman, R. A., Jabbar, L., & Shalal, S. H. (2026). Integrated assessment of the serum magnesium-to-vitamin D3 ratio, micronutrient deficiencies, and inflammatory biomarkers in patients with migraine. Regulatory Mechanisms in Biosystems, 17(5), e26093. https://doi.org/10.15421/0226093

Vancouver

Alrahman RA, Jabbar L, Shalal SH. Integrated assessment of the serum magnesium-to-vitamin D3 ratio, micronutrient deficiencies, and inflammatory biomarkers in patients with migraine. Regulatory Mechanisms in Biosystems. 2026;17(5):e26093. doi:10.15421/0226093

BibTeX
@article{Alrahman2026,
  author = {Alrahman, R. A. and Jabbar, L. and Shalal, S. H.},
  title = {Integrated assessment of the serum magnesium-to-vitamin D3 ratio, micronutrient deficiencies, and inflammatory biomarkers in patients with migraine},
  journal = {Regulatory Mechanisms in Biosystems},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {e26093},
  doi = {10.15421/0226093}
}
Start for free →